Cancer Therapy Market Overall Study Report 2023-2030

Cancer therapies help treat cancer, reduce the size of cancer, or stop the progression of cancer. These therapies include chemotherapy, radiation therapy, immunotherapy, and targeted therapy. Drugs are used in chemotherapy to kill cancer cells. It is a pharmacological therapy that uses potent chemicals to kill the body’s rapidly proliferating cells. High-energy radiation is used in radiation treatment to treat cancer. A type of cancer treatment known as immunotherapy aids the immune system’s battle against the disease. A type of cancer treatment known as targeted therapy targets the alterations in cancer cells that promote their growth, division, and spread.

Major factors anticipated to propel growth of the global cancer therapy market include rising cancer prevalence in the world, rising need for safe and effective cancer therapies, government initiatives to raise cancer awareness, and rising research and development efforts by key industry players.

For instance, the Indian Council for Medical Research (ICMR) projects that by 2025, there will be 29.8 million cancer patients in India, up from 26.7 million in 2021. As a result, the region’s share of the global market for cancer therapy is growing as cancer prevalence rises and cancer therapies are more in demand.

Key features of the study:

  • This report provides in-depth analysis of the global cancer therapy market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global cancer therapy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer Inc., Novartis AG, Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline PLC, Hoffmann-La Roche Ltd., Bayer AG, AstraZeneca, Amgen, and Bristol-Myers Squibb Company, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global cancer therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapy market.

Detailed Segmentation:

  • Global Cancer Therapy Market, By Treatment Type:
    • Chemotherapy
    • Target Therapy
    • Immunotherapy Therapy
    • Hormone Therapy
    • Others
  • Global Cancer Therapy Market, By Cancer Type:
    • Blood Cancer
    • Breast Cancer
    • Prostate cancer
    • Skin Cancer
    • Lung Cancer
    • Others
  • Global Cancer Therapy Market, By End User:
    • Hospital
    • Specialty Clinic
    • Radiation Center

Leave a Reply

Your email address will not be published. Required fields are marked *